టెల్మా-సిటి 40/1215 ట్యాబ్లెట్లు గల 5 స్ట్రిప్స్

Drug-Drug Interactions

Telma-CT 40/12.5 Tablet may interact with certain medications, potentially affecting its effectiveness or increasing the risk of side effects. Inform your doctor about all prescription medicines, over-the-counter products, and supplements you are taking, including:

• Lithium: Concurrent use may increase lithium levels in the blood, raising the risk of lithium toxicity. Close monitoring is usually required if both medicines are used together.
• NSAIDs (such as ibuprofen, naproxen, or diclofenac): Regular use of nonsteroidal anti-inflammatory drugs may reduce the blood pressure-lowering effects of Telma-CT 40/12.5 Tablet and increase the risk of kidney function impairment.
• Other Blood Pressure Medications: Combining this medicine with other antihypertensive drugs may lead to an excessive reduction in blood pressure, causing dizziness, weakness, or fainting.
• Potassium-Sparing Diuretics or Potassium Supplements: These may increase potassium levels in the blood, potentially leading to hyperkalaemia, which can affect heart rhythm.
• Other Diuretics (Water Pills): Concurrent use may increase the risk of dehydration, electrolyte imbalances, or excessively low blood pressure.
• Antidiabetic Medicines: Blood sugar levels may be affected, and dosage adjustments of diabetes medications may occasionally be necessary.

Drug-Food Interactions

Certain foods and beverages may influence the effects of Telma-CT 40/12.5 Tablet . Consider the following precautions:

• Alcohol: Alcohol may enhance the blood pressure-lowering effect of this medicine, increasing the risk of dizziness, light-headedness, or fainting, particularly when standing up suddenly.
• Salt Substitutes Containing Potassium: Potassium-based salt substitutes should be used cautiously, as they may increase blood potassium levels and raise the risk of hyperkalaemia.
• Maintain Adequate Hydration: Excessive fluid loss from vomiting, diarrhoea, or inadequate fluid intake may increase the risk of dehydration and low blood pressure during treatment.

Drug-Disease Interactions

Certain medical conditions may require special precautions or monitoring while taking Telma-CT 40/12.5 Tablet . Tell your doctor if you have any of the following:

• Kidney Disease: This medicine may affect kidney function, particularly in patients with existing kidney impairment. Regular monitoring of kidney function may be required.
• Liver Disease: Patients with liver impairment may experience altered drug metabolism and may require careful dose adjustment and monitoring.
• Diabetes: The chlorthalidone component may influence blood glucose levels, making periodic monitoring and possible adjustments to diabetes treatment necessary.
• Gout: Chlorthalidone can increase uric acid levels in the blood, potentially triggering or worsening gout attacks.
• Electrolyte Imbalances: Conditions associated with abnormal potassium, sodium, magnesium, or calcium levels may be worsened and require monitoring during treatment.
• Dehydration or Low Blood Volume: Patients with significant fluid loss may be at greater risk of excessive blood pressure reduction and kidney-related side effects.